Seminars in Hematology

Papers
(The TQCC of Seminars in Hematology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
CAR T-cell therapy comes of age: Introductory editorial for the special issue62
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial58
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies52
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation50
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?46
Clinical applications of circulating tumor DNA in Hodgkin lymphoma44
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1943
How to set up a clinical research center in Brazil, as an example of a middle-income country41
Epidemiology and etiology of diffuse large B-cell lymphoma39
TET2 mutation as prototypic clonal hematopoiesis lesion37
Somatic mutations in “benign” blood diseases37
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services34
Antibody and immunotherapy in diffuse large B-cell lymphoma30
Lessons learned from the Eµ-TCL1 mouse model of CLL27
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence26
The role of viruses in HIV-associated lymphomas24
Vaccinations in patients with chronic lymphocytic leukemia22
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future21
The molecular map of CLL and Richter's syndrome19
Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?17
Report of Consensus Panel 5 from the 12th International Workshop on Waldenström’s Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors17
outside front cover, PMS 8883 metallic AND 4/C16
outside front cover, PMS 8883 metallic AND 4/C16
Tribute to an editor: Neal S. Young As a Medical Editor and Writer15
Clonal hematopoiesis15
At the cusp of a cure in Myeloma: Insights into pathogenesis, modeling and therapeutics14
outside front cover, PMS 8883 metallic AND 4/C13
Cellular and immunotherapies for myelodysplastic syndromes13
B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients13
Management of Myelodysplastic Syndrome in Pregnant Patients: Treatment Approaches and Considerations12
Challenges and opportunities of CAR T-cell therapies for CLL11
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead11
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia11
Mendelian inheritance of anemia due to disturbed iron homeostasis10
Aplastic anemia: Quo vadis?10
Mobilizing CARs: Benefits, drawbacks, and directions for outpatient CAR T-cell therapy9
Access to essential therapy for sickle cell disease in Africa: Experience from a national program in Ghana9
The biology of classical Hodgkin lymphoma9
The psychiatric and psychological sequelae of vaccine-induced immune thrombotic thrombocytopenia (VITT)9
The pediatric approach to Hodgkin lymphoma8
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS8
VEXAS within the spectrum of rheumatologic disease8
Somatic mutations in acquired pure red cell aplasia7
Iron and erythropoiesis: A mutual alliance7
Understanding MDS stem cells: Advances and limitations7
Genetics of somatic auto-inflammatory disorders7
Report of consensus panel 2 from the 12th international workshop on the management of Bing-Neel syndrome in patients with Waldenstrom’s Macroglobulinemia7
Somatic compensation of inherited bone marrow failure7
0.042891979217529